Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Glenmark Pharmaceuticals Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

22 Aug 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Glenmark Pharmaceuticals Ltd (GLENMARK-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

28 Aug 2015 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Glenmark Pharmaceuticals Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

20 Aug 2015 Wright Reports 56 $75.00

Spark Capital: 1QFY16 outlook review of Glenmark Pharmaceuticals (Rating: Buy, TP: Rs.1,209)

1QFY16 outlook review of Glenmark Pharmaceuticals (Rating: Buy, TP: Rs.1,209) How does our one year outlook change? Glenma...

13 Aug 2015 Spark Capital Advisors(India) Private Limited 6 $46.00

MOSL: Glenmark Pharma - Performance in the US and SRM remain weak - sales miss est. by 10%-Downgrade to Neutral

GLENMARK PHARMA 1QFY16: Performance in the US and SRM remain weak; sales miss est. by 10% (GNP IN, Mkt Cap USD4.3b, CMP INR1...

03 Aug 2015 Motilal Oswal Securities Ltd. 14 $150.00

Glenmark Pharmaceuticals Ltd. | Q1FY16 Result Update | Though a weak quarter; outlook remain promising; upgrade to BUY with revise price target to Rs1,163 (from Rs896 earlier)

Glenmark Pharmaceuticals Ltd. | Q1FY16 Result Update Though a weak quarter; outlook remain promising; upgrade to BUY with r...

03 Aug 2015 IndiaNivesh Securities Pvt Ltd 5 $46.00

Glenmark Pharmaceuticals (GNP) - Qtr. Update - Dated - July 31, 2015

Glenmark Pharma (Bloomberg: GNP IN; HOLD; TP – Rs 960; 5% downside from CMP of Rs 1,010) Glenmark’s (GNP) Q1 EBITDA margin...

31 Jul 2015 Axis Capital Limited 8 $81.00

GLEN.NS - Event Transcript of Glenmark Pharmaceuticals Ltd conference call, Jul. 30, 2015 / 11:00PM ET

Edited Event Transcript of GLEN.NS conference call, Jul. 30, 2015 / 11:00PM ET Boston, Jul 31, 2015 (Thomson StreetEven...

30 Jul 2015 Thomson Reuters StreetEvents 28 $75.00

Is Glenmark Pharmaceuticals Ltd a Good Long-Term Investment?

03 Jun 2015 Sadif Analytics Prime 11 $25.00

MOSL: Glenmark Pharma ((Buy) - Results marred by one-offs - FY16 outlook robust

GLENMARK PHARMA 4QFY15: Results marred by one-offs; FY16 outlook robust (GNP IN, Mkt Cap USD3.2b, CMP INR865, TP INR950, 10%...

02 Jun 2015 Motilal Oswal Securities Ltd. 12 $127.00